Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1 (original) (raw)

Profile image of Joshua CostinJoshua Costin

1999, Peptides

visibility

description

9 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets

zodwa dlamini

Viruses-Basel, 2014

View PDFchevron_right

Broad activation of latent HIV-1 in vivo

Ole Søgaard

Nature Communications, 2016

View PDFchevron_right

A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor

Xiaohe Tong

Journal of Molecular Biology, 2008

View PDFchevron_right

Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection

Eva M Fenyö

New England Journal of Medicine, 2012

View PDFchevron_right

Cytopathic Mechanisms of HIV-1

Joshua Costin

Virology Journal, 2007

View PDFchevron_right

HIV-1 Replication Is Inhibited by a Pseudo-substrate Peptide That Blocks Tat Transactivation

Takashi Okamoto

Virology, 2000

View PDFchevron_right

The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway

Helena Vieira

Cell Death and Differentiation, 2002

View PDFchevron_right

8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19-22 July 2015, Vancouver, Canada

Constancia Watadzaushe

Journal of the International AIDS Society, 2015

View PDFchevron_right

Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages

kamel mabrouk

Peptides 1994, 1995

View PDFchevron_right

HIV-1 Super Infection

Maria Pernas

Microbes, Viruses and Parasites in AIDS Process, 2011

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Uncoating of HIV-1 requires cellular activation

Pilaipan Puthavathana

Virology, 2005

View PDFchevron_right

Gut disruption in HIV-2 infection despite reduced viremia

Ana Rita Pires

AIDS, 2014

View PDFchevron_right

Solution structure of peptides from HIV-1 Vpr protein that cause membrane permeabilization and growth arrest

Ian Macreadie

Journal of Peptide Science, 1998

View PDFchevron_right

Interactions between endothelial cells and HIV-1

Stefania Maria Filomena Mitola

2001

View PDFchevron_right

Assessment of HIV-1 integration in tissues and subsets across infection stages

Fernanda Torres

JCI Insight, 2020

View PDFchevron_right

Loss of Infectivity of HIV-1 Particles Produced by Mobile Lymphocytes

Cecilia Ramirez

PLoS ONE, 2014

View PDFchevron_right

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo

Beverly Sha

Journal of Immunology, 1996

View PDFchevron_right

On the way to find a cure: Purging latent HIV-1 reservoirs

Carine Van Lint

Biochemical Pharmacology, 2017

View PDFchevron_right

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Dimitrios Paraskevis

Journal of the International AIDS Society

View PDFchevron_right

Indinavir plasma protein binding in HIV-1-infected adults

Rory Remmel

AIDS, 2000

View PDFchevron_right

Vulnerabilidade de mulheres vivendo com HIV/Aids

Marli Teresinha Cassamassimo Duarte

Revista Latino-americana De Enfermagem, 2014

View PDFchevron_right

HIV, ‘An evolving species’. Roles of cellular activation and co-infections

Yves Plumelle

Medical Hypotheses, 2003

View PDFchevron_right

Ayodele HIV publication 2

Aaron, Umasoye Udogadi

View PDFchevron_right

Interferon-α Produces Significant Decreases in HIV Load

Jorge Tavel

2010

View PDFchevron_right

Towards an HIV cure: science and debate from the International AIDS Society 2013 symposium

Damian Purcell

Retrovirology, 2013

View PDFchevron_right

HIV-1 entry – an expanding portal for drug discovery

Nicholas Meanwell

Drug Discovery Today, 2000

View PDFchevron_right

A New Controversial Pathophysiology Confirms that HIV does not Kill the CD4+ T-Cell But Mutates Its Physiological Behavior Becoming an Unaccountable CD8+ T-Cell

Sherif Salah

Journal of AIDS & Clinical Research, 2016

View PDFchevron_right

Second Generation Inhibitors of HIV-1 Maturation

Nicholas Meanwell

ACS Medicinal Chemistry Letters, 2019

View PDFchevron_right

Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction

Doug Mack

The Journal of Immunology, 2007

View PDFchevron_right

Toxicity and drug exposure in a quadruple drug regimen in HIV–1 infected patients participating in the ADAM study

Richard Hoetelmans

AIDS, 2000

View PDFchevron_right

Delayed progression and inefficient transmission of HIV-2

Bineeta Kashyap

Southeast Asian J Trop …, 2010

View PDFchevron_right

Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees

Mark Connors

AIDS, 1991

View PDFchevron_right

Immunologic Targets of HIV Infection: T Cells

Clemente Díaz

Annals of the New York Academy of Sciences, 1993

View PDFchevron_right

Triple HIV-1 Infection

Ben Berkhout

New England Journal of Medicine, 2005

View PDFchevron_right

The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals

Keith Nye

Journal of Immunology, 1997

View PDFchevron_right

PhysiologyElectron MicroscopyScanning Electron MicroscopyApoptosisHIVCell DeathP-glycoproteinPeptidesHuman immunodeficiency virusNecrosisAmino Acid SequenceMolecular Sequence DataPharmacology and pharmaceutical ...